Exploit: Ransomware

10x Genomics Inc.: Biotechnology company

Risk to Small Business: 2.206 = Severe

A ransomware attack disrupted operations at the biotechnology company, which is currently acting as part of a consortium working to quickly develop a treatment for COVID-19. Before encrypting IT, hackers exfiltrated company data. Although the company reports “no material day-to-day impact,” it’s unclear what the implications are for the stolen data or how this could impact its development of a COVID-19 treatment.

Individual Risk: At this time, no personal information was compromised in the breach.

Customers Impacted: Unknown

How it Could Affect Your Customers’ Business: Companies in every sector have seen an uptick in cybersecurity threats as COVID-19 disrupts business-as-usual and puts many people on edge. This is especially true for the healthcare industry, which is experiencing a deluge of ransomware attacks, phishing scams, and other threats at a critical time.

Source:
https://www.cyberscoop.com/covid-19-ransomware-10x-genomics-data-breach/